Alpha Tau CFO to Present at Sidoti Small Cap Conference
Event summary
- Alpha Tau CFO Raphi Levy to present at Sidoti Virtual Small Cap Conference on March 18, 2026.
- Presentation scheduled for 10:00–10:30 AM ET.
- Levy will be available for 1x1 investor meetings during the conference.
- Alpha Tau develops Alpha DaRT®, a cancer therapy using alpha-radiation.
The big picture
Alpha Tau's participation in the Sidoti Small Cap Conference underscores its efforts to engage with investors amid a competitive landscape in oncology therapeutics. The company's focus on alpha-radiation therapy positions it within a niche segment of cancer treatment, but its success hinges on clinical validation and market adoption. The presentation offers a platform to showcase progress and attract potential investors.
What we're watching
- Investor Sentiment
- How Alpha Tau's presentation will impact investor confidence in its Alpha DaRT technology.
- Market Positioning
- Whether Alpha Tau can differentiate itself in the competitive oncology therapeutics space.
- Regulatory Progress
- The pace at which Alpha DaRT advances through clinical trials and regulatory approvals.
Related topics